Registry for implantable cardiac devices
Registry of Device Implantation in University Hospital Duesseldorf
Heinrich-Heine University, Duesseldorf · NCT03360227
This study is tracking how well pacemakers and defibrillators work for people with heart rhythm problems to see if they can improve patient care and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Heinrich-Heine University, Duesseldorf (other) |
| Locations | 1 site (Düsseldorf) |
| Trial ID | NCT03360227 on ClinicalTrials.gov |
What this trial studies
This registry focuses on the implantation of cardiac devices such as pacemakers and implantable cardioverter-defibrillators, which are standard procedures in managing cardiac arrhythmias. It aims to evaluate the efficacy and safety of these devices while identifying clinical and procedural factors that may influence patient outcomes. By monitoring advancements in device technology and patient care, the registry seeks to enhance the overall management of patients with conditions like syncope, bradycardia, and sudden cardiac death.
Who should consider this trial
Good fit: Ideal candidates for this registry include patients undergoing implantation of cardiac devices for conditions such as syncope, bradycardia, and tachycardia.
Not a fit: Patients who do not provide written informed consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved patient outcomes and tailored therapies for individuals with cardiac arrhythmias.
How similar studies have performed: Other studies have shown success in monitoring and improving outcomes with similar device implantation approaches, indicating a promising avenue for patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. pre-operative clinical history taking 2. pre-operative functional investigations (cardiac echo, electrocardiograms) 3. pre-operative laboratory data evaluation (kidney function, liver function, biomarkers, thyroid hormone, CBC) Exclusion Criteria: １. no written informed consent
Where this trial is running
Düsseldorf
- Division of Cardiology, Pulmonary Disease and Vascular Medicine — Düsseldorf, Germany (RECRUITING)
Study contacts
- Principal investigator: Hisaki Makimoto, MD — Division of Cardiology, Pulmonary Disease and Vascular Medicine
- Study coordinator: Hisaki Makimoto, MD
- Phone: +492118118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Syncope, Bradycardia, Tachycardia, Sudden Cardiac Death, Ventricular Tachycardia, Ventricular Fibrillation, syncope, bradycardia